A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency

Thrombosis and Haemostasis

Volumn 98, Issue 4, 2007, Pages 783-789

  Yin, Tong ^a   Takeshita, Satoshi ^a   Sato, Yukiko ^a   Sakata, Toshiyuki ^a   Shin, Yongchol ^a   Honda, Shigenori ^a   Kawasaki, Tomio ^b   Tsuji, Hajime ^c   Kojima, Tetsuhito ^d   Madoiwa, Seiji ^e   Sakata, Yoichi ^e   Murata, Mitsuru ^f   Ikeda, Yasuo ^f   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Deep vein thrombosis; Gene deletion; MLPA; PROS1; Protein S deficiency

Indexed keywords

PROTEIN PROS1; PROTEIN S; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CENTROMERE; CHROMOSOME 3; DEEP VEIN THROMBOSIS; DNA SEQUENCE; FEMALE; GENE DELETION; GENETIC SCREENING; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN S DEFICIENCY; QUANTITATIVE ANALYSIS; RISK FACTOR; SEQUENCE ANALYSIS; VALIDATION PROCESS;

ADULT; BLOOD PROTEINS; CENTROMERE; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; JAPAN; MALE; MICROSATELLITE REPEATS; MODELS, GENETIC; POINT MUTATION; PROTEIN S DEFICIENCY; RISK FACTORS; VENOUS THROMBOSIS;

EID: 35048820909     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-03-0211     Document Type: Article

References (35)

1. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-662.
2. Dykes AC, Walker ID, McMahon AD, et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
3. Sakata T, Okamoto A, Mannami T, et al. Prevalence of protein S deficiency in the Japanese general population: the Suita Study. J Thromb Haemost 2004; 2: 1012-1013.
4. Beauchamp NJ, Dykes AC, Parikh N, et al. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 2004; 125: 647-654.
5. Kimura R, Honda S, Kawasaki T, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 2006; 107: 1737-1738.
6. Kinoshita S, Iida H, Inoue S, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005; 38: 908-915.
7. Miyata T, Kimura R, Kokubo Y, et al. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 2006; 83: 217-223.
8. Kimura R, Sakata T, Kokubo Y, et al. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers. J Thromb Haemost 2006; 4: 2010-2013.
9. Watkins PC, Eddy R, Fukushima Y, et al. The gene for protein S maps near the centromere of human chromosome 3. Blood 1988; 71: 238-241.
10. Edenbrandt CM, Lundwall A, Wydro R, et al. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-7868.
11. Ploos van Amstel HK, Reitsma PH, van der Logt CP, et al. Intron-exon organization of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-7861.
12. Schmidel DK, Tatro AV, Phelps LG, et al. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-7852.
13. Gandrille S, Borgel D, Sala N, et al. Protein S deficiency: a database of in mutations-summary of the first update. Thromb Haemost 2000; 84: 918.
14. Lanke E, Johansson AM, Hillarp A, et al. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1. J Thromb Haemost 2004; 2: 1918-1923.
15. Ploos van Amstel HK, Huisman MV, Reitsma PH, et al. Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 1989; 73: 479-483.
16. Schmidel DK, Nelson RM, Broxson EH, Jr., et al. A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 1991; 77: 551-559.
17. Holmes ZR, Bertina RM, Reitsma PH. Characterization of a large chromosomal deletion in the PROS1 gene of a patient with protein S deficiency type I using long PCR. Br J Haematol 1996; 92: 986-991.
18. Johansson AM, Hillarp A, Sall T, et al. Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency. Thromb Haemost 2005; 94: 951-957.
19. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
20. Sellner LN, Taylor GR. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 2004; 23: 413-419.
21. Koolen DA, Vissers LE, Pfundt R, et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 2006; 38: 999-1001.
22. Lai KK, Lo IF, Tong TM, et al. Detecting exon deletions and duplications of the DMD gene using Multiplex Ligation-dependent Probe Amplification (MLPA). Clin Biochem 2006; 39: 367-372.
23. Rooms L, Reyniers E, Wuyts W, et al. Multiplex ligation-dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clin Genet 2006; 69: 58-64.
24. Sakata T, Okamoto A, Mannami T, et al. Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Tbromb Haemost 2004; 2: 528-530.
25. Hoebeeck J, van der Luijt R, Poppe B, et al. Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest 2005; 85: 24-33.
26. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: Research0034.
27. Okuda T, Fujioka Y, Kamide K, et al. Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387-394.
28. Kimura R, Kokubo Y, Miyashita. K, et al. Polymorphisms in vitamin K-dependent γ-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol 2006; 84: 387-397.
29. Tanaka C, Kamide K, Takiuchi S, et al. An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
30. Lakich D, Kazazian HH, Jr., Antonarakis SE, et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-241.
31. Tatewaki H, Tsuda H, Kanaji T, et al. Characterization of the human protein S gene promoter: a possible role of transcription factors Sp1 and HNF3 in liver. Thromb Haemost 2003; 90: 1029-1039.
32. Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002; 18: 74-82.
33. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454.
34. Bailey JA, Gu Z, Clark RA, et al. Recent segmental duplications in the human genome. Science 2002; 297: 1003-1007.
35. Shaw CJ, Lupski JR. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 2004; 13: R57-64.